A phase II, open-label study of gefitinib (IRESSA) in patients with locally advanced, metastatic, or relapsed renal-cell carcinoma - Concepedia

Concepedia

Publication | Closed Access

A phase II, open-label study of gefitinib (IRESSA) in patients with locally advanced, metastatic, or relapsed renal-cell carcinoma

58

Citations

29

References

2005

Year

Monika Jermann, Rolf A. Stahel, Marc Salzberg, Thomas Cerny, Markus Joerger, Silke Gillessen, Rudolf Morant, F Egli, K Rhyner, Jean Bauer,

Cancer Chemotherapy and Pharmacology

UrologyRenal-cell CarcinomaPhase IiGenitourinary CancerMedicineCancer TreatmentOpen-label StudyOncologyRadiation Oncology

References

	Year	Citations

Page 1

Page 1